VIP

Vasoactive Intestinal Peptide (VIP) is a versatile neuropeptide extensively studied for its wide-ranging physiological effects. In the gastrointestinal system, VIP regulates nutrient absorption, gut motility, and immune function, making it a potential therapeutic agent for conditions like diabetes and cancer. Its presence in the central nervous system points to important roles in neurobiology and mental health. VIP also exhibits strong immunomodulatory effects, offering promise for the treatment of inflammatory diseases. Additionally, it influences endocrine activity, particularly in pituitary gland function. Ongoing research is investigating VIP’s role in neurological disorders such as Alzheimer’s disease and Autism Spectrum Disorders, highlighting its broad therapeutic potential.